Physician
Dermatology
Dr. Wilma F. Bergfeld, MD
|
|
Give Review
Wilma F. Bergfeld, MD is an expert in the field of Dermatology. She attended Temple University School of Medicine. She over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Fellow (FASDS)". Wilma Bergfeld is also a published doctor. She has 100 paper published. The most recent paper is: Langerhans cell microabscesses, but not eosinophils, are clues to a diagnosis of allergic contact dermatitis in appropriate skin biopsies. She is registered with Medicare and accepts Medicare payments.
Publications
- Prevalence of Comorbid Conditions and Sun-Induced Skin Cancers in Patients with Alopecia Areata.
- Eosinophilic Esophagitis: Another Atopy-Related Alopecia Areata Trigger?
- Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
- ILK Index and Regrowth in Alopecia Areata.
- The use of oral pioglitazone in the treatment of Lichen planopilaris.
- Colocalization of vitiligo and alopecia areata presenting as poliosis.
- Safety Assessment of Animal- and Plant-Derived Amino Acids as Used in Cosmetics.
- Amended safety assessment of hypericum perforatum-derived ingredients as used in cosmetics.
- Safety Assessment of Vitis vinifera (Grape)-Derived Ingredients as Used in Cosmetics.
- Safety assessment of modified terephthalate poLymers as used in cosmetics.
- Safety assessment of 6-hydroxyindole as used in cosmetics.
- Safety Assessment of PEGylated Oils as Used in Cosmetics.
- Safety Assessment of Dimethicone CrosspoLymers as Used in Cosmetics.
- Safety Assessment of Chlorphenesin as Used in Cosmetics.
- Safety Assessment of Cucumis sativus (Cucumber)-Derived Ingredients as Used in Cosmetics.
- Safety Assessment of Citric Acid, Inorganic Citrate Salts, and Alkyl Citrate Esters as Used in Cosmetics.
- Association of Lichen planopilaris with thyroid disease: A retrospective case-control study.
- Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind ...
- Universal protocol for alopecia areata clinical studies.
- Growth hormone deficiency in a young patient with alopecia areata.
- Safety assessment of ammonium hectorites as used in cosmetics.
- Safety Assessment of α-Amino Acids as Used in Cosmetics.
- Amended safety assessment of formaldehyde and methylene glycol as used in cosmetics.
- Nonspecific Histopathological Diagnoses: The Impact of Partial Biopsy and the Need for a Consensus Guideline.
- Safety assessment of decyl glucoside and other alkyl glucosides as used in cosmetics.
- Safety assessment of lauriminodipropionic Acid, sodium lauriminodipropionate, and disodium lauriminodipropionate as used in cosmetics.
- Safety assessment of bis-diglyceryl polyacyladipate-2 and bis-diglyceryl polyacyladipate-1 as used in cosmetics.
- Safety assessment of alkyl glyceryl ethers as used in cosmetics.
- Safety assessment of borosilicate glasses as used in cosmetics.
- Cutaneous intravascular extramedullary hematopoiesis in a patient with post-polycythemia vera myelofibrosis.
- Safety assessment of 2-amino-4-hydroxyethylaminoanisole and 2-amino-4-hydroxyethylaminoanisole sulfate as used in cosmetics.
- Safety assessment of diethanolamides as used in cosmetics.
- Safety assessment of triethanolamine and triethanolamine-containing ingredients as used in cosmetics.
- Safety assessment of silylates and surface-modified siloxysilicates.
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis.
- Safety assessment of isoparaffins as used in cosmetics.
- Safety assessment of trimoniums as used in cosmetics.
- Safety assessment of alkyl benzoates as used in cosmetics.
- Morphologic mimickers of Cryptococcus occurring within inflammatory infiltrates in the setting of neutrophilic Dermatitis: a series of three cases highlighting clinica...
- Hair: What is New in Diagnosis and Management?: Female Pattern Hair Loss Update: Diagnosis and Treatment.
- Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy.
- Final report of the Amended Safety Assessment of PVM/MA copoLymer and its related salts and esters as used in cosmetics.
- Fluoroscopy-induced chronic radiation Dermatitis: a report of two additional cases and a brief review of the literature.
- Iron deficiency and Hair loss-Nothing new?
- Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of PoLymethyl Methacrylate (PMMA), Methyl Methacrylate CrosspoLymer, and Methyl Methacryl...
- Amended safety assessment of sesamum indicum (sesame) seed oil, hydrogenated sesame seed oil, sesamum indicum (sesame) oil unsaponifiables, and sodium sesameseedate.
- Final report of the safety assessment of cosmetic ingredients derived from zea mays (corn).
- Final Report on the Safety Assessment of Cocos nucifera (Coconut) Oil and Related Ingredients.
- Advancement of women in dermatology.
- Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia: A Population Study.
- Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics.
- Final amended safety assessment of hydroquinone as used in cosmetics.
- Final report of the safety assessment of Kojic acid as used in cosmetics.
- Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients.
- Inadequate biopsy technique and specimen size: an alarming trend that compromises patient care and an appeal to our clinical colleagues.
- Final report of the safety assessment of methylisothiazolinone.
- Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics.
- Final report of the amended safety assessment of sodium laureth sulfate and related salts of sulfated ethoxylated alcohols.
- Final safety assessment of thiodipropionic acid and its dialkyl esters as used in cosmetics.
- Update on the management of hirsutism.
- Final report on the safety assessment of sodium cetearyl sulfate and related alkyl sulfates as used in cosmetics.
- Final report of the amended safety assessment of Quaternium-15 as used in cosmetics.
- Final report of the safety assessment of allantoin and its related complexes.
- Final amended report of the safety assessment of toluene-2,5-diamine, toluene-2,5-diamine sulfate, and toluene-3,4-diamine as used in cosmetics.
- Quantitative analysis of eosinophils in acute graft-versus-host Disease compared with drug hypersensitivity reactions.
- Final report on the safety assessment of Basic Violet 1, Basic Violet 3, and Basic Violet 4.
- Diseases of the hair and Nails.
- Amended safety assessment of tall oil acid, sodium tallate, potassium tallate, and ammonium tallate.
- Final report on the safety assessment of amino nitrophenols as used in Hair dyes.
- Amended safety assessment of sodium picramate and picramic acid.
- Grover Disease (transient acantholytic dermatosis).
- Apocrine Carcinoma in situ of sweat duct origin.
- A histologic review of 27 patients with Lichen planopilaris.
- A case-series of 29 patients with Lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment.
- What is your diagnosis? Uncombable Hair syndrome (pili trianguli et canaliculi).
- Histopathologic evaluation of alopecias.
- The diagnosis and treatment of iron deficiency and its potential relationship to Hair loss.
- Differences in biopsy techniques of Actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study.
- Alopecia areata: what to expect from current treatments.
- Metastatic gastric adenoCarcinoma presenting as an enlarging plaque on the scalp.
- When to ask your dermatopathologist to evaluate for surgical margins and when not: a matter of confusion for dermatologists and dermatopathologists alike.
- A retrospective biopsy study of the clinical diagnostic accuracy of common Skin diseases by different specialties compared with dermatology.
- "Lesion," "rule out...," and other vagaries of filling out pathology requisition forms.
- Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid Sarcoma.
- Evaluation and treatment of male and female pattern Hair loss.
- Safety of ingredients used in cosmetics.
- The pathophysiology of Acne vulgaris in children and adolescents, part 2: Tailoring treatment.
- The pathophysiology of Acne vulgaris in children and adolescents, Part 1.
- Women leaders in American dermatology. Interview by Marylou C. Thelmo, E. Dorinda Shelley, Gloria F. Graham.
- Primary cutaneous coccidioidomycosis.
- Beryllium Dermatitis.
- Hair loss: diagnosis and management.
- Toward optimal health: the experts discuss facial Skin and related concerns in women.
- Long-term implications of T-Cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-Cell lymphoma.
- Occupational alopecia or alopecia areata?
- Microcystic adnexal Carcinoma (MAC) of the scalp with extensive pilar differentiation.
- Safety assessment of nylon as used in cosmetics.
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis.
- Langerhans Cell microabscesses, but not eosinophils, are clues to a diagnosis of allergic contact dermatitis in appropriate skin biopsies.
Schools
Temple University School Of Medicine
Cleveland Clin Hospital
Afip
Cleveland Clinic
Procedures Preformed
- Acne Surgery
- Chemical Peel
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatopathology
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Fellow (FASDS)
Education
-
Cleveland Clinic Foundation -
Temple University School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1013972207 | |
| NPPES Provider LastName | BERGFELD | |
| NPPES Provider FirstName | WILMA | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Dermatology | |
| Total Claim Count | 152.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013972207 |
| Last Name Of The Provider | BERGFELD |
| First Name Of The Provider | WILMA |
| View All |
Similar Doctors
|
|
Dr. Suparna Mullick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer D. Bahner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle B. Tarbox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milford E. Gottlob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip L. Bailin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Bass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Jaworsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal G. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Berna Remzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren C. Payne, MD |
|
|
Margaret A. Bobonich, NP
This Doctor is OpenDoctor Recommended.
|